England
No more silly photos for a while - fell off my bike!
| Name | Distance Points | Day Points | Encourager Points | Total Points |
|---|---|---|---|---|
| Total Score | 1539 | 680 | 200 | 2419 |
| Sean Lynn | 222 | 70 | 50 | 342 |
| Emma Koppe | 257 | 60 | 0 | 317 |
| Emma Koppe | 231 | 60 | 0 | 291 |
| Simon Hicks | 25 | 30 | 150 | 205 |
| Martin Scott | 159 | 40 | 0 | 199 |
| Name | Department | Last login | ||
|---|---|---|---|---|
| Olufunke Akiyode | SFC (UK) | 9 months | Encourage | |
| Petra Booij | SFC (UK) | 9 months | Encourage | |
| Alistair Greenlaw | Product Development | 10 months | Encourage | |
| Victoria Lando | SFC (UK) | 11 months | Encourage | |
| Guilherme De Castro | Medicine Design | 1 year | Encourage | |
| David King | almost 2 years | Encourage | ||
| Sam Payne | almost 2 years | Encourage | ||
| Bob Watson | Epinova | over 2 years | Encourage | |
| Matthew Cooke | Drug Substance and Product Analysis | almost 3 years | Encourage | |
| Grant Hollis | GSK Tech | 3 years | Encourage |
| Name | staff | Riders | Distance (miles) | Trips | Transport Trips |
|---|---|---|---|---|---|
| CMC Analytical | 100 | 0 | 0 | 0 | 0 |
| PSDE | 50 | 1 | 104 | 32 | 0 |
| PTS-DDS | 250 | 1 | 186 | 19 | 10 |
| AS | 100 | 1 | 69 | 3 | 2 |
| CSci | 400 | 0 | 0 | 0 | 0 |
| BPR | 3 | 3 | 6223 | 314 | 83 |
| GAC | 50 | 2 | 1188 | 44 | 5 |
| Biopharm Innovation | 50 | 1 | 4 | 1 | 1 |
| Respiratory | 30 | 6 | 8475 | 667 | 317 |
| Respiratory | 30 | 3 | 2699 | 221 | 66 |
| DMS | 12 | 0 | 0 | 0 | 0 |
| R&D S&P | 12 | 2 | 20 | 7 | 5 |
| ATD | 40 | 3 | 76 | 8 | 8 |
| AIML | 15 | 0 | 0 | 0 | 0 |
| Emcor Engineering | 120 | 0 | 0 | 0 | 0 |
| SM Tech | 50 | 0 | 0 | 0 | 0 |
| CGT | 400 | 6 | 6753 | 654 | 248 |
| AIRU | 120 | 3 | 1695 | 109 | 93 |
| Bioimaging | 30 | 2 | 1038 | 114 | 34 |
| QPPV Office | 8 | 0 | 0 | 0 | 0 |
| CDQA | 30 | 0 | 0 | 0 | 0 |
| Epinova | 100 | 2 | 1071 | 298 | 107 |
| GDS | 3 | 0 | 0 | 0 | 0 |
| LAS | 60 | 0 | 0 | 0 | 0 |
| Product Development | 50 | 4 | 15891 | 404 | 19 |
| TSci | 200 | 1 | 6 | 1 | 1 |
| CPEM Biomarkers | 9 | 1 | 130 | 25 | 0 |
| SFC (UK) | 48 | 6 | 12455 | 962 | 221 |
| Biopharm R&D | 3 | 2 | 5960 | 274 | 46 |
| ComputationalBiology | 40 | 1 | 1066 | 66 | 1 |
| RMA | 15 | 0 | 0 | 0 | 0 |
| BSci | 80 | 0 | 0 | 0 | 0 |
| SEMA QA | 3 | 0 | 0 | 0 | 0 |
| Data & Computational Science | 400 | 5 | 4309 | 259 | 17 |
| Drug Substance and Product Analysis | 100 | 1 | 1813 | 95 | 49 |
| CPEM Discovery Medicine | 15 | 2 | 33 | 7 | 1 |
| IVSD | 20 | 1 | 5 | 2 | 2 |
| BIB | 12 | 1 | 3434 | 290 | 36 |
| Medicine Design | 600 | 5 | 9828 | 991 | 750 |
| WREF | 200 | 4 | 12829 | 2538 | 1776 |
| Strategy Portfolio & Operations | 3 | 1 | 7944 | 261 | 7 |
| Discovery DMPK | 25 | 1 | 163 | 40 | 40 |
| C3 | 20 | 1 | 8 | 4 | 4 |
| SPMB | 60 | 1 | 65 | 10 | 6 |
| GSK Tech | 50 | 2 | 1443 | 102 | 15 |
| Tech Stewards | 8 | 1 | 6 | 1 | 1 |
| Biostatistics | 100 | 1 | 1 | 1 | 0 |
| IBPS | 3 | 1 | 20 | 1 | 0 |
| This can be deleted. | 1 | 0 | 0 | 0 | 0 |
